Over the years, thanks to the increase in scientific knowledge in the diagnostic and therapeutic field and the refinement of molecular biology techniques, the management of cancer patients has been completely revolutionized. The foundations of precision cancer medicine were laid on this knowledge, which made it possible to move toward targeted choices, thanks to the identification of specific and unique molecular biomarkers that act as drivers for the use of target therapies. In this chapter, we summarize future perspectives on the subject.
Incorvaia L., La Mantia M., Cutaia S., Gristina V., Galvano A., Barraco N., et al. (2022). Future perspectives. In Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology (pp. 221-225). Elsevier [10.1016/B978-0-12-822703-9.00019-3].
Future perspectives
Incorvaia L.;Cutaia S.;Gristina V.;Galvano A.;Barraco N.;Badalamenti G.;Russo A.;Bazan V.
2022-01-01
Abstract
Over the years, thanks to the increase in scientific knowledge in the diagnostic and therapeutic field and the refinement of molecular biology techniques, the management of cancer patients has been completely revolutionized. The foundations of precision cancer medicine were laid on this knowledge, which made it possible to move toward targeted choices, thanks to the identification of specific and unique molecular biomarkers that act as drivers for the use of target therapies. In this chapter, we summarize future perspectives on the subject.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Future perspectives.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
102.72 kB
Formato
Adobe PDF
|
102.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
